NASDAQ: BEAM
Beam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?

Insider buying vs selling

Have Beam Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy SimonMed2026-07-2716,667$25.74
$429.04kSell
John M. EvansCEO2026-06-3023,100$34.26
$791.48kSell
John M. EvansCEO2026-06-301,900$34.84
$66.20kSell
Amy SimonChief Medical Officer2026-06-30373$34.73
$12.95kSell
John M. EvansCEO2026-06-3025,000$1.03
$25.75kBuy
John M. EvansCEO2026-06-2913,421$35.13
$471.53kSell
John M. EvansCEO2026-06-2918,663$0.67
$12.50kBuy
John M. EvansCEO2026-06-2911,579$35.91
$415.83kSell
John M. EvansCEO2026-06-296,337$1.03
$6.53kBuy
Fmr LLC10% Owner2026-06-26251,488$35.26
$8.87MSell

1 of 5

BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BEAM insiders and whales buy or sell their stock.

BEAM Shareholders

What type of owners hold Beam Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC4.33%4,467,741$108.43MInsider
Robert Nelsen3.42%3,535,572$85.81MInsider
Arch Venture Partners IX LLC2.86%2,949,630$71.59MInsider
Kristina Burow2.66%2,747,530$66.68MInsider
Redmile Group LLC1.12%1,161,458$28.19MInsider
John M. Evans1.11%1,150,205$27.92MInsider
Giuseppe Ciaramella0.25%253,911$6.16MInsider
Christine Bellon0.11%109,711$2.66MInsider
Sravan Kumar Emany0.10%105,456$2.56MInsider
Amy Simon0.08%85,696$2.08MInsider

1 of 3

BEAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BEAM0.11%16.19%Net SellingNet Selling
GPCR0.03%10.37%Net SellingNet Buying
IRON0.11%65.28%Net SellingNet Selling
CLDX0.11%16.22%Net Buying
IMNM0.10%4.06%Net SellingNet Selling

Beam Therapeutics Stock Ownership FAQ

Who owns Beam Therapeutics?

Beam Therapeutics (NASDAQ: BEAM) is owned by 0.11% institutional shareholders, 16.19% Beam Therapeutics insiders, and 83.71% retail investors. Fmr LLC is the largest individual Beam Therapeutics shareholder, owning 4.47M shares representing 4.33% of the company. Fmr LLC's Beam Therapeutics shares are currently valued at $108.25M.

If you're new to stock investing, here's how to buy Beam Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.